Comments on Dr Ralph Moss’ critique of German New Medicine
By Don Benjamin
Moss has written a scathing
critique of Dr Ryke Geerd Hamer’s German New Medicine (GNM)1.
It is a very useful report because it contains many facts that are hard to track
down and provides useful information about other groups that have carried out
assessments of German New Medicine.
refers to but has clearly not read the details of the Five Biological Laws
of GNM. He then tries to assess the GNM based on claims that GNM
does not make.
He quotes examples of testimonials from a website and then claims
that they do not include adequate information or documentation for an outsider
to use them for assessing the benefits of the therapy
claims benefits for orthodox medicine that remain unproven and
ridicules those who question such claims
accepts the claims of orthodox practitioners that the metastasis
process involves circulating cancer cells
despite there being very little evidence for the claimed mechanism; and
criticises those who question such an unproven claim.
claims that ring structures in brain CTs must be artifacts, not
biological phenomena, trusting the opinions of medical specialists and
ridiculing evidence from researchers (such as Bjőrn Nordenstrőm from Karolinska
Hospital in Stockholm) who, like Hamer suggested an alternative explanation for
some of them.
Moss also assessed the
statistics for success claimed for GNM treatment and came to the reasonable
conclusion that the claim of 92% 5-year survival for 6,500 of Hamer’s cancer
patients treated from 1990-1995 was invalid. However there are some faults in
Finally he devoted over 10%
of the report to showing that Hamer was
Anti-Semitic, and providing evidence that he was ‘delusional’. The implication
from this was that his ‘unreason’ can therefore be extended to his medical
thinking. This again displays a lack of logic.
The Five Principles
Moss paraphrases Hamer’s five biological
laws or rules, then completely misrepresents their implications for the
therapy. For example, GNM states that the reaction of an individual to an
unanticipated event depends on the part of the brain affected by the event:
old, primitive, reptilian brain (brainstem), the part affected in animals;
middle brain (cerebellum and cerebral medulla); or
new brain (cerebral cortex), present only in higher animals and humans2.
that reactions in animals and birds can only occur in the old brain and are
instinctive reactions to unanticipated events (such as a deer observing her fawn
being killed) that threaten the integrity of the herd or nest. He does not use
the word ‘emotions’ but describes the conflicts in humans and higher mammals,
such as anger, as “inter-animal, at least for us mammals…man [suffers these
conflicts] mostly in a transposed sense (for example, verbal mediation)” and
these, when part of interpersonal relationships, are experienced in the cerebral
the section Latency Period (Lag Time) (Page 61) Moss states
that “In medical science the latency period is generally measured in years,
sometimes even in decades, and not in days, weeks or months. This is one of the
sharpest points of disagreement between GNM and modern oncology”. He argues
that “Hamer’s own testicular tumour diagnosed about two months after his son’s
demise” therefore could not have been caused by his son’s death.
on the previous page in Cancer in Children (page 60) he also
argues that tumours cannot be caused by emotional shock because neuroblastomas
are observed in 1-year old children and “sometimes even present at birth. In
fact, neuroblastoma is sometimes detected in utero, before the birth of the
child! ….Babies, much less foetuses, are insufficiently aware of their
surroundings to suffer from mature emotional conflicts…” By using this example,
Moss not only undermines his argument on the Latency Period of tumours, but also
reveals a lack of knowledge or awareness of modern holistic principles, such as
those described by Bruce Lipton4. These suggest
that the cell’s environment picks up external stresses even before birth. To
suggest that a foetus is unaffected by the mother’s emotional reaction to an
unanticipated event shows a serious ignorance of the proven link between
emotions and the chemicals they produce5 and which
can travel via the placenta to the foetus. There is also the holistic principle
that emotions and chemicals are just different forms of energy and cells respond
to energy in all its forms, not depending only on the receptors on the cell’s
the Section on Asbestos and Mesothelioma (page 61) Moss argues
that as this tumour has a latency period of between 15 and 50 years it could not
possibly be caused by an unanticipated event.
is general agreement among orthodox practitioners that some benign tumours can
become malignant in a relative short space of time. In fact it is known that
relatively easily observed cervical tumours fluctuate backwards and forwards
between the benign and malignant states during a matter of months6.
It is therefore possible for there to be a non-malignant tumour developing over
a 40 year period after exposure to asbestos that could rapidly become malignant
after an unanticipated event and produce symptoms within a year. Moss is surely
aware of this phenomenon. He makes the same argument in relation to the latency
period in the case of radiation and thyroid cancer (28-36 years), xenoestrogens
and testicular cancer (median period 20 years) and tobacco and lung cancer
must be a definitive diagnosis of cancer
must be documentation recording the tumour’s response to the treatment (tumour
must be no other therapies that might have produced the response (confounders);
must be a documented history including dates and types of interventions and
responses during the period in question.
for orthodox therapies
One of Moss’ main criticisms
of GNM is based on the fact that Hamer was opposed to all orthodox therapies on
the grounds that they were not only ineffective but also harmful and
antagonistic to the healing process. Therefore Hamer and his supporters cause
many deaths because “it will alarm many scientifically unsophisticated patients
and might induce them to abandon potentially curative treatments (such as
surgery for early-stage cancer)”. Moss makes this statement in the context of
chemotherapy where he cites Hamer as stating in December 2004 that “the usual
survival rate of patients treated traditionally is only 2 to 3 percent,
according to the German Cancer Research Centre in Heidelberg”. Moss attributes
this to the findings of Ulrich Abel whose statistics referred to advanced
epithelial cancer (ie late stage solid tumours). He says “Hamer misuses Abel’s
findings, by extending them to cancer treatment as a whole, and ignoring
developments over the past 20 years. It is an absurd caricature of the state of
This reveals an inconsistency in Moss’
thinking. Firstly, in relation to surgery for early stage cancer,
has never been a single randomised controlled clinical trial that shows any
survival benefit from surgery for any type of cancer compared to no surgery7
the randomised controlled trials comparing different degrees of surgical
intervention for breast cancer show no difference in survival8
the randomised controlled trials evaluating the benefits of screening show no
overall survival benefits from early detection and treatment of cancer9.
So Moss’ own claim that
surgery for early-stage cancer is potentially curative is unproven.
As far as chemotherapy is
concerned, a recent study by Australian medical scientists has confirmed that
chemotherapy for solid tumours adds only 2.3 percent to five-year survival10.
Adding non-epithelial cancers, such as leukaemia, increases this figure to
around 3 percent. Adding surgery (for tumours threatening vital organs, such as
obstructing the bowel) and radiotherapy for similar situations and some other
rare cancers takes the figure to about 7 percent.
So Moss’ claim that survival
benefits of 2 to 3 percent “is an absurd caricature of the state of cancer
therapy” is not borne out by the latest statistics.
For example, James Devitt (the eminent
Canadian breast cancer surgeon who was the keynote speaker at the Lancer Breast
Cancer Conference in Belgium in 1994) questioned the role of circulating cancer
cells in metastases because, for breast cancer cells to spread to the usual
metastatic sites would require them to travel through or past many other organs
where metastases also occur, yet do not in many cases12.
For example a cell spreading from an invasive intraductal breast carcinoma would
have to travel through the pulmonary capillaries, the intestinal capillary bed
and renal capillary beds. Yet only some of these patients exhibit “metastases”
in the liver, lungs, intestine, kidney, abdominal lymph nodes or adrenals. He
asks why some women get metastases in one or more of these sites but not
others. He concludes:
….If the breast lesion is not the cause of the disease but merely the local expression of a combination of changes in both local and systemic growth-restraining factors, and if such a combination was more or less specific for producing breast-tissue-like growths, they would be more easily induced and occur earlier in breast tissue. Occurrence in other tissues or sites would be later for this reason rather than because mechanical spread had taken place. This might explain the entirely different "metastatic" pattern and courses [in different] patients.
might appear in the regional lymph nodes because of a greater concentration of
abnormal growth controlling humours in the lymph draining there; the tumour
might even produce such humours. Perhaps lesions manifest in other organs and
tissues because the release from growth restraint allows the greater growth
potential of embryonic cell ancestors to
body’s internal milieu, including the strength of the immune system, determines
if cancer can grow anywhere in the body
the time any tumour has started to grow, and before it is detected, cancer is
already a systemic disease (Devitt12,
cancer process can reverse itself if the internal milieu reverts to normal, eg
by a weakened immune system returning to normal
the cancer process continues, the first tumour is detected in the most
susceptible site, for example one where there is the most tissue damage or
repair taking place, or because
the release from growth restraint allows the greater growth
potential of embryonic cell ancestors to
or where (in Dr Hamer’s terminology) an emotional
trauma might produce a conflict- mechanism determined by the person’s reaction
to the unanticipated event.
appearance of a particular tumour is characteristic of the tissue where it first
arises, so all breast tumours that arise in breast gland tissue look similar and
different from tumours in different organs. (Devitt suggests that breast
tumours are so-called only because they are usually first seen in breast tissue,
this being the most susceptible tissue for that type of cancer12.)
the cancer process continues, second tumours arise in the next most susceptible
tissue, which might be nearby lymph nodes.
the cancer process still continues unchecked, tumours are detected in tissues of
more remote organs as their tissue becomes the next most susceptible to tumour
growth. The cells of the tumour would resemble those of the primary tumour
because it was caused by the same emotional trauma, not necessarily because it
had spread from the primary site.
always occur after “primary” tumours, often after a lengthy time delay.
describes how, as tumours grow, they gradually undermine the body’s digestive,
endocrine, metabolic and immune systems13. So it
should not be surprising that such later stage cancers would be invariably
fatal. Slow growing tumours are characterised by lengthy survival (such as with
most prostate cancers) with little opportunity for metastases to develop before
the person dies from other causes; with fast-growing tumours the growth
restraining factors are much weaker so shorter survival would be expected, with
time for “metastases” to develop.
If it is claimed by cancer specialists
that metastasised cancer cells are linked to primary tumours by their
appearance, then, according to Hamer’s hypothesis, the cancer cells of a
metastatic tumour would only resemble those of the primary tumour if there were
a second emotional trauma similar to the original one that caused the primary
tumour. If a poor prognosis further undermined the immune system and
accelerated the existing cancer process, it would accelerate tumour growth of
the same type. If the poor prognosis were a new unanticipated event
different from the first one and caused another tumour, as Hamer suggests, its
appearance would be completely different and unrelated to the primary tumour. In
this sense Dr Hamer’s explanation of metastases resulting from the unanticipated
doctor’s diagnosis, particularly a poor prognosis, would often be invalid.
The metastasis theory also does not
explain those cancers where no primary tumour was discovered.
So Moss is not justified in claiming
metastases via spreading are a proven phenomenon just because most cancer
experts claim it is so. However he has identified an inconsistency in Hamer’s
Ring Structures in X-rays
The appearance of concentric rings on
earlier X-rays and more modern CT scans has been known for a long time. For
example Dr Björn Nordernström, Professor of Diagnostic Radiology at the
Karolinska Institut and Hospital in Stockholm observed them in lung X-rays in
the 1950s. He asked his colleagues what they were. They suggested he ignore
them as they were unexplained artefacts. Instead he chose to ignore his
colleagues and explaining the mysterious ‘corona structures’ prompted him to
carry out further research. He discovered they were caused by an uneven
distribution of water due to altered extracellular fluid dynamics, caused in
turn by fluctuating electrical potentials.
After several more years of research he
had developed a completely new paradigm of what cancer is and how it could be
treated. In the process he confirmed the existence of chakras and their
importance in health. Because of opposition to his approach, which questioned
the current cancer paradigm he was, like Hamer, forced to publish his findings
himself in 198314.
He continued his research in China, where the orthodox and alternative paradigms
often co-exist in the same hospitals and research centres.
The claimed success statistics
The one area where Moss is on more solid
ground is in his questioning of Hamer’s claim that 92 percent of 6,500 cancer
patients treated by him had survived 5 years. Moss tried without success to
establish documentation for these statistics, which had allegedly been arrived
at by the public prosecutor in Hamer’s trial. Moss was not able to identify the
prosecutor in question who was alleged to have provided such statistics.
According to Moss, Austrian health
authorities closed down Hamer’s Cancer Clinic in Burgau, Austria in late 1995
(or early 1996). Moss states that “during this 5-year period (1990-1995), by
Hamer’s account, he saw a total of about 6,500 patients” (page 35). Moss argues
that only those patients treated during 1990 would have had reached a 5-year
anniversary of their treatment by the end of 1995. (In fact the period from 1990
to the end of 1995 (or early 1996) is longer than 5 years.)
Moss argues that it would not have been
possible to track down 6,500 patients in the time available to the prosecutor.
He overlooks an alternative possibility: With such large numbers involved it
would have been more practicable to follow up a few hundred of those treated in
1990 to gain a representative sample. However the prosecutor would have no
interest in finding recovered cancer patients. He would only require
documentation on a small number to show Hamer had treated them illegally (as
happened in Josef
A more realistic estimate came from an
investigation by the German magazine Der Spiegel through the German
authorities. They identified 50 patients with metastatic cancer who had been in
the care of Hamer and only 7 had survived. An appraisal by Ventegodt et al of
Hamer’s five “medical laws” included the statement that, in reference to the Der
Spiegel finding, “we find that when treated only with psychosocial intervention,
a success rate of 15% with this group of mortally ill metastatic cancer patients
is remarkable and encouraging for further research”15.
The Ventegodt Appraisal
On page 71 of his report Moss refers to
an academic assessment of Hamer’s work by researchers in the field of holistic
medicine led by Søren Ventegodt, MD. Unlike Moss they concluded that
“Altogether, it seems that Hamer is in accordance with
contemporary holistic medical theory, as the most fundamental principles of his
work are built on an understanding very similar to holistic medical thinkers of
today and of the past; regarding the most fundamental postulate that cancer
patients can be healed by his system of holistic medicine could actually be the
case for some of the motivated patients. This must be tested scientifically,
however, before being accepted. If proven, we must recommend a rehabilitation of
the name and work of Ryke Geerd Hamer. Clinical testing of a cure for cancer
based on Hamer's system must be considered worth the effort; it must be done
with physicians trained by Hamer if at all possible.”15
They in fact found that the first two of Hamer’s laws were “in agreement with the theories acknowledged by modern holistic medicine such as the theory of coherence by Aaron Antonovsky (1923-1994) that explains that health comes from re-establishing “coherence”. This is related to the work and ideas of Abraham Harold Maslow (1908-1970) and Viktor Emil Frankl (1905-1997) and the most progressive “resilience” literature, as well as our own work: the theory of the purpose of life and the life mission theory that explain that the cause of much suffering and disease results from resignation of the purpose of life”.
(These two laws state that all cancer forms arise from an emotional and biological shock; and that every disease has a pathogenic and a healing phase).
They were however unable to substantiate the remaining three rules (the symbolic linkage between psyche to the brain and the organs of the body; the claim that bacteria and viruses are controlled by the body and help the body in the healing process; and the claim that all diseases are rational and natural processes for the benefit of the patient). They came to this conclusion by comparing Hamer’s claims with those of accepted orthodox biological processes, which they had no reason to question, in contrast with the first two laws, where there was much evidence, based on an alternative paradigm, on which to make an assessment.
of delusional thinking on medical thinking
Moss uses 11 of the 86 pages of analysis (~12%) to show that Dr Hamer is anti-Semitic and delusional and concludes from this that “his unsupportable fantasies are more properly classified as signs of profound mental derangement” (page 84). Moss then states that Hamer’s “ranting about an imaginary worldwide Jewish conspiracy is more than just prejudiced; it is delusional… and speaks volumes about his state of mind … One can detect much of the same paranoia, sloppiness and unreason in his medical thinking as in his social views” (page 85).
The evidence Moss presents for Hamer’s anti-Semitism is very strong, as is his evidence for Hamer’s paranoia. However, it is understandable how a person who believes strongly in having discovered a way of saving thousands of lives only to be prosecuted and imprisoned for refusing to recant his beliefs, might feel. In fact on page 88 Moss recounts the story of Ignaz Semmelweis, the 19th century Hungarian physician who was scorned by his contemporaries because he urged them to scrub their hands to prevent the transmission of childbed fever. He died in a mental hospital. One can understand how Semmelweis felt after he had successfully almost eliminated childbirth deaths from infection after implementing this simple precaution in his hospital, only to be ridiculed by the rest of his profession and his career destroyed.
The question Moss does not explore is, was Hamer “anti-Semitic”, “paranoid” and “mentally deranged” at the time he developed his German New Medicine” or did he only display these tendencies after his medical colleagues set out to destroy him for his heresies? This is critical to the validity of Moss’ conclusions, as he states that a person in this state would be incapable of logical thinking.
Moss’ report is also useful in revealing the philosophy behind the Complementary and Alternative Medicine (CAM) movement in the United States, in particular the NCI’s Office of Cancer Complementary and Alternative Medicine (OCCAM) set up in October 1998. (It now operates in competition to the National Institute of Health’s National Centre for Complementary and Alternative Medicine (NCCAM) that he helped set up (as the Office of Alternative Medicine) in 1992. Both organisations receive ~$125 million in annual funding.) Moss states (page 74) that “To make conventional medicine more humanistic is CAM’s raison d’être”. It is therefore not surprising that anyone such as Hamer, who rejects most conventional cancer intervention, would be considered to have nothing beneficial among his theories and principles.
factor is that German New Medicine is clearly part of psychotherapy. This area
of therapy has received almost no recognition by supporters of conventional
medicine despite having at least six randomized controlled clinical trials that
show dramatic effects on survival with cancer patients
16-20. Opposition to the idea that cancer
might be caused by psychological or emotional trauma therefore appears to be
based more on ideological grounds than any lack of scientific evidence. The
implications of this evidence ever becoming accepted are world shattering, if
only because the cancer industry worldwide is worth in excess of $500 billion a
year, and this industry is based entirely on a particular paradigm about what
cancer is. Therapies based on this paradigm appear to provide benefits to barely
7% of those treated. Psychotherapies such as those developed by Ronald
and Hamer, if found to be effective, would ultimately sound the death knell of
orthodox cancer therapies.
CancerDecisions.com, Newsletter #402, 08/02/09
Introducing 'German New Medicine®'-Hope Or Hoax?
2. Dr. med. Mag. Theol. Ryke Geerd Hamer.
Scientific Chart of Germanic New Medicine. Amici di Dirk 2007.
3. Dr. med. Mag. Theol. Ryke Geerd Hamer.
Summary of the new medicine, 3rd edition, Amici di Dirk 2000, (p49).
4. Lipton, BH. The Biology of Belief:
Unleashing the Power of Consciousness, Matter & Miracles. Hay House, 2008.
5. Pert, C. Molecules of Emotion. Simon &
Schuster, New York, 1997, and as a Touchstone Book in 1999.
6. Green GH. Duration of Symptoms and Survival
Rates for Invasive Cervical Cancer. Aust & NZ Journal of Obstet and Gynec 1970;
7. Benjamin, DJ. The efficacy of surgical
treatment of cancer. Medical Hypotheses 1993; 40 (2): 129-138.
8. Benjamin, DJ. The efficacy of surgical
treatment of breast cancer. Medical Hypotheses 1996; 47 (5):
9. Black W, Haggerstrom D and Welch HG.
All-cause Mortality in Randomized Trials of Cancer Screening. J Natl Cancer
Inst, 6 Feb 2002; 94(3):167-73.
10. Morgan G et al. The contribution of
cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol (R
Coll Radiol). (Dec) 2004; 16(8): 549-60.
11. Gebski, V et al. Survival effects of Postmastectomy Adjuvant Radiation
Therapy using Biologically Equivalent Doses: A Clinical Perspective. JNCI 2006;
98 (1): 26-38.
12. Devitt JE. Breast
cancer: have we missed the forest because of the tree? Lancet 1994; 344:
13. Issels, Josef.
Cancer: A Second Opinion. Hodder and Stoughton, London, 1975.
14. Nordenström. B. Biologically Closed Electric Circuits: Clinical,
Experimental and Theoretical Evidence for an Additional Circulatory System.
Nordic Medical Publications, Sweden, 1983.
15. Ventegodt, S et al. Rationality and Irrationality in Ryke Geerd Hamer’s
System for Holistic Treatment of Metastatic Cancer. The Scientific World Journal
2005; 5: 93-102.
16. Fawzy FI et al.
Malignant melanoma Effects of a brief, structured psychiatric intervention on
survival and recurrence at 10-year follow-up. Arch Gen Psychiatry
2003; 60: 100-3.
17. Eysenck, HJ & Grossarth-Maticek, R. Creative Novation Behaviour Therapy as
a Prophylactic Treatment for Cancer and Coronary Heart Disease: Part II -
Effects of Treatment. Behav Research and Therapy 1991; 29 (1): 17-31.
(includes results from three randomised trials).
18. McCorkle et al. A specialized home care intervention improves survival
among older post-surgical cancer patients. J Am Geriatr Soc. 2000; 48:1707-13.
19. Kuchler T et al. Impact of psychotherapeutic support on gastro-intestinal
cancer patients undergoing surgery; survival results of a trial.
Hepato-Gasteroenterol 1999; 46: 322-35.
20. Cunningham A et al. A randomised controlled trial of the effects of group
psychological therapy on survival in women with metastatic breast cancer.
Psycho-oncology 1998; 7: 508-17.